drugset / Trial / NCT01720576
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This is a study to assess the safety and tolerability of subcutaneously administered REGN1033 (SAR391786) in healthy volunteers.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trevogrumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.